CINC

CinCor Pharma, Inc. Common Stock
CINC

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CINC was delisted on the 23rd of February, 2023.

Back to rankings

53 hedge funds and large institutions have $520M invested in CinCor Pharma, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$97.8M
2
+$76.1M
3
+$72.4M
4
PA
Perceptive Advisors
New York
+$40.7M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$36.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$97.8M
2
$76.1M
3
$72.4M
4
$40.7M
5
$36.6M
6
$34.7M
7
$30.4M
8
$24.4M
9
$18.1M
10
$16.9M
11
$16.7M
12
$12.6M
13
$11.9M
14
$10.9M
15
$3.66M
16
$2.17M
17
$1.75M
18
$1.56M
19
$1.44M
20
$1.4M
21
$1.32M
22
$911K
23
$613K
24
$568K
25
$565K
1
2 3